UBS Assumes West Pharmaceutical (WST) at Buy
UBS analyst Douglas Schenkel assumes coverage on West Pharmaceutical (NYSE: WST) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
